NOP2 and invasive breast carcinoma: In BRCA patients, DNMT1, NOP2, DNMT3A, FMR1, RBM15 and YTHDF2 were highly elevated, while WTAP, TET2, ALKBH3 and TRDMT1 were dramatically downregulated (Fig. 9B).